Dr. Ken He Young

Dr. Ken He Young |Clyto Access

University of Texas, USA

Advisory Board Member
Editorial Board Member

Expertise: Leukemia, EBV+ lymphoma, TP53, MYC molecular target pathway, clinical trails of EBV+ lymphoma

Bio:
Dr. Ken He Young is an Associate Professor in The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, TX. He is also among the scientific review panel of Lymphoma Research Foundation and Leukemia and Lymphoma Society, Houston, TX. Dr. Ken He Young is a NIH/NCI funded scientist for his research on for clinical trails of EBV+ lymphoma, TP53 and MYC molecular target pathway, clinical trails of EBV+ lymphoma, TP53 and MYC molecular target pathway.

Related Journals & Conferences :

International Journal of Transplantation Research and Technology

Global Forum on Transplantation Research and Technologies